Earnings results for Enzo Biochem (NYSE:ENZ)
Enzo Biochem, Inc. is expected* to report earnings on 10/12/2021 before market open. The report will be for the fiscal Quarter ending Jul 2021. The reported EPS for the same quarter last year was $-0.07.
Enzo Biochem has confirmed that its next quarterly earnings report will be published on Tuesday, October 12th, 2021. Enzo Biochem will be holding an earnings conference call on Tuesday, October 12th at 8:30 AM Eastern. Interested parties can register for or listen to the call..
Analyst Opinion on Enzo Biochem (NYSE:ENZ)
like Enzo Biochem stock less than the stock of other Medical companies. 66.88% of gave Enzo Biochem an outperform vote while medical companies recieve an average of 67.30% outperform votes by .
Dividend Strength: Enzo Biochem (NYSE:ENZ)
Enzo Biochem does not currently pay a dividend. Enzo Biochem does not have a long track record of dividend growth.
Insiders buying/selling: Enzo Biochem (NYSE:ENZ)
In the past three months, Enzo Biochem insiders have not sold or bought any company stock. Only 9.20% of the stock of Enzo Biochem is held by insiders. 49.80% of the stock of Enzo Biochem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Earnings and Valuation of Enzo Biochem (NYSE:ENZ
The P/E ratio of Enzo Biochem is 133.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.54. The P/E ratio of Enzo Biochem is 133.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 31.72. Enzo Biochem has a P/B Ratio of 3.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here